|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 2200 Lake Boulevard NE |
Address2 |
|
City | ATLANTA |
State | GA |
Zip Code | 30319 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 320873-12
|
||||||||
|
6. House ID# 395670000
|
TYPE OF REPORT | 8. Year | 2018 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Adam Cooper |
Date | 1/22/2019 5:15:43 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.J. Res. 143, Continuing appropriations for fiscal year 2019. (P.L. 115-298)
H.R. 6, SUPPORT for Patients and Communities Act. (P.L. 115-271)
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1898, To improve access to, and utilization of, bone mass measurement benefits.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017.
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018.
H.R.6157, Defense and Labor, Health and Human Services Consolidated Appropriations Act, 2019. (P.L. 115-245)
H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 898, Conrad State 30 and Physician Access Reauthorization Act.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 2553, Know the Lowest Price Act of 2018 (P.L. 115-262).
S. 2554, Patient Right to Know Drug Prices Act (P.L. 115-263).
S. 2908, To provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
S. 3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 3159, Department of Defense Appropriations Act, 2019.
S. 3160, To improve access to, and utilization of, bone mass measurement benefits.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Adam |
Cooper |
|
|
|
Lennie |
Shewmaker |
|
|
|
Kayla |
Amodeo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.J. Res. 143, Continuing appropriations for fiscal year 2019. (P.L. 115-298)
H.R. 6, SUPPORT for Patients and Communities Act. (P.L. 115-271)
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1898, To improve access to, and utilization of, bone mass measurement benefits.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017.
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018.
H.R.6157, Defense and Labor, Health and Human Services Consolidated Appropriations Act, 2019. (P.L. 115-245)
H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 898, Conrad State 30 and Physician Access Reauthorization Act.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 2553, Know the Lowest Price Act of 2018 (P.L. 115-262).
S. 2554, Patient Right to Know Drug Prices Act (P.L. 115-263).
S. 2908, To provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
S. 3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 3159, Department of Defense Appropriations Act, 2019.
S. 3160, To improve access to, and utilization of, bone mass measurement benefits.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Adam |
Cooper |
|
|
|
Lennie |
Shewmaker |
|
|
|
Kayla |
Amodeo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Monitor implementation of the Patient Protection and Affordable Care Act (P.L. 111-148).
Monitor federal and legislative activity related to Medicare Reimbursement.
Monitor federal issues and legislation associated with health care policy.
Monitor implementation of Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10).
Monitor implementation of 21st Century Cures Act (P.L. 114-255).
H.R. 6, SUPPORT for Patients and Communities Act.
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017.
H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act.
H.R. 1316, Prescription Drug Price Transparency Act.
H.R. 1628, American Health Care Act of 2017.
H.R. 1703, Medical Product Communications Act of 2017.
H.R. 1898, To improve access to, and utilization of, bone mass measurement benefits.
H.R. 1920, To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
H.R.2077, Restoring the Patient's Voice Act of 2017.
H.R. 2141, Conrad State 30 and Physician Access Reauthorization Act.
H.R. 2267, Resident Physician Shortage Reduction Act of 2017.
H.R. 2641, Promoting Life-Saving New Therapies for Neonates Act of 2017.
H.R. 2999, Patients' Access to Treatments Act of 2017.
H.R. 3635, Local Coverage Determination Clarification Act of 2017.
H.R. 3728, EMPOWER Act of 2017.
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017.
H.R. 4841, Standardizing Electronic Prior Authorization for Safe Prescribing Act of 2018.
H.R. 5150, Protecting Medicare from Excessive Price Increases Act of 2018.
H.R.6157, Defense and Labor, Health and Human Services Consolidated Appropriations Act, 2019.
H.R. 6470, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 251, Protecting Medicare from Executive Action Act of 2017.
S. 260, Protecting Seniors' Access to Medicare Act of 2017.
S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017.
S. 794, Local Coverage Determination Clarification Act of 2017.
S. 898, Conrad State 30 and Physician Access Reauthorization Act.
S. 989, Ensuring Children's Access to Specialty Care Act of 2017.
S. 1301, Resident Physician Shortage Reduction Act of 2017.
S. 1304, A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare, and for other purposes.
S. 2553, Know the Lowest Price Act of 2018 (P.L. 115-262).
S. 2554, Patient Right to Know Drug Prices Act (P.L. 115-263).
S. 2908, To provide for electronic prior authorization under Medicare part D for covered part D drugs, and for other purposes.
S. 3158, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019.
S. 3160, To improve access to, and utilization of, bone mass measurement benefits.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Adam |
Cooper |
|
|
|
Lennie |
Shewmaker |
|
|
|
Kayla |
Amodeo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IMM
16. Specific lobbying issues
Outreach and monitoring federal and legislative activity related to the Deferred Action
for Childhood Arrivals program.
Monitor implementation of revised Travel Ban Executive Order 13780 and related
actions.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Adam |
Cooper |
|
|
|
Kayla |
Amodeo |
|
|
|
Lennie |
Shewmaker |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |